Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors

Journal of Neuroscience

Volumn 33, Issue 18, 2013, Pages 7728-7741

  Lotfipour, Shahrdad ^a   Byun, Janet S ^a   Leach, Prescott ^b   Fowler, Christie D ^c   Murphy, Niall P ^a   Kenny, Paul J ^c   Gould, Thomas J ^b   Boulter, Jim ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BODY POSITION; BREATHING; COGNITION; CONTROLLED STUDY; FEAR; FEMALE; GENE; GENE DELETION; INTERPEDUNCULAR NUCLEUS; LOCOMOTION; MALE; MAZE TEST; MOTOR COORDINATION; MOUSE; NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT GENE ALPHA 2; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STARTLE REFLEX; TREMOR;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; CONDITIONING, CLASSICAL; DRUG ADMINISTRATION SCHEDULE; ESCAPE REACTION; EXPLORATORY BEHAVIOR; FEAR; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; NEUROTRANSMITTER AGENTS; NICOTINE; NICOTINIC AGONISTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECEPTORS, NICOTINIC; REFLEX; STARTLE REACTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84877109504     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4731-12.2013     Document Type: Article

References (61)

1. Alvarez FJ, Fyffe RE (2007) The continuing case for the Renshaw cell. J Physiol 584:31-45. CrossRef Medline
2. Aridon P, Marini C, Di Resta C, Brilli E, De Fusco M, Politi F, Parrini E, Manfredi I, Pisano T, Pruna D, Curia G, Cianchetti C, Pasqualetti M, Becchetti A, Guerrini R, Casari G (2006) Increased sensitivity of the neuronal nicotinic receptor α 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 79:342-350. CrossRef Medline
3. Barros DM, Ramirez MR, Izquierdo I (2005) Modulation of working, shortand long-term memory by nicotinic receptors in the basolateral amygdala in rats. Neurobiol Learn Mem 83:113-118. CrossRef Medline
4. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, De Marchi N, Papadimitriou GN, et al. (1998) Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20:70-73. CrossRef Medline
5. Caggiula AR, Epstein LH, Perkins KA, Saylor S (1995) Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms. Psychopharmacology (Berl) 122:301-306. CrossRef Medline
6. Corley RP, Zeiger JS, Crowley T, Ehringer MA, Hewitt JK, Hopfer CJ, Lessem J, McQueen MB, Rhee SH, Smolen A, Stallings MC, Young SE, Krauter K (2008) Association of candidate genes with antisocial drug dependence in adolescents. Drug Alcohol Depend 96:90-98. CrossRef Medline
7. Covernton PO, Lester RA (2002) Prolonged stimulation of presynaptic nicotinic acetylcholine receptors in the rat interpeduncular nucleus has differential effects on transmitter release. Int J Dev Neurosci 20:247-258. CrossRef Medline
8. Crawley JN (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15:695-699. CrossRef Medline
9. Damaj MI, Kao W, Martin BR (2003) Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther 307:526-534. CrossRef Medline
10. Davis JA, Gould TJ (2007) β2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology (Berl) 190:343-352. CrossRef Medline
11. Davis JA, James JR, Siegel SJ, Gould TJ (2005) Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J Neurosci 25:8708-8713. CrossRef Medline
12. Davis JA, Kenney JW, Gould TJ (2007) Hippocampal α4β2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J Neurosci 27:10870-10877. CrossRef Medline
13. Ellison G (2002) Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry. Eur Neuropsychopharmacol 12:287-297. CrossRef Medline
14. Fowler CD, Kenny PJ (2011) Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training. Neuropharmacology 61:687-698. CrossRef Medline
15. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ (2011) Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471: 597-601. CrossRef Medline
16. Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S, Filkin S, Pons S, Fontaine JF, Tsetlin V, Maskos U, Ibañez-Tallon I (2011) Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula. Neuron 70:522-535. CrossRef Medline
17. Girod R, Role LW (2001) Long-lasting enhancement of glutamatergic synaptic transmission by acetylcholine contrasts with response adaptation after exposure to low-level nicotine. J Neurosci 21:5182-5190. Medline
18. Girod R, Barazangi N, McGehee D, Role LW (2000) Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology 39:2715-2725. CrossRef Medline
19. Glick SD, Sell EM, McCallum SE, Maisonneuve IM (2011) Brain regions mediating β3α4 nicotinic antagonist effects of 18-MC on nicotine selfadministration. Eur J Pharmacol 669:71-75. CrossRef Medline
20. Gould TJ, Lewis MC (2005) Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning. Learn Mem 12:389-398. CrossRef Medline
21. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, Petursson H, Curtis D (2001) Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68:661-673. CrossRef Medline
22. Han ZY, Le Novère N, Zoli M, Hill JA Jr, Champtiaux N, Changeux JP (2000) Localization of n ACh R subunit m RNAs in the brain of Macaca mulatta. Eur J Neurosci 12:3664-3674. CrossRef Medline
23. Heitjan DF, Guo M, Ray R, Wileyto EP, Epstein LH, Lerman C (2008) Identification of pharmacogenetic markers in smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet 147B:712-719. CrossRef Medline
24. Hentall ID, Gollapudi L (1995) The interpeduncular nucleus regulates nicotine's effects on free-field activity. Neuroreport 6:2469-2472. CrossRef Medline
25. Iles JF, Ali A, Pardoe J (2000) Task-related changes of transmission in the pathway of heteronymous spinal recurrent inhibition from soleus to quadriceps motor neurones in man. Brain 123:2264-2272. CrossRef Medline
26. Ishii K, Wong JK, Sumikawa K (2005) Comparison of α2 nicotinic acetylcholine receptor subunit m RNA expression in the central nervous system of rats and mice. J Comp Neurol 493:241-260. CrossRef Medline
27. Jackson KJ, Martin BR, Changeux JP, Damaj MI (2008) Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325:302-312. CrossRef Medline
28. Jia Y, Yamazaki Y, Nakauchi S, Sumikawa K (2009) α2 nicotine receptors function as a molecular switch to continuously excite a subset of interneurons in rat hippocampal circuits. Eur J Neurosci 29:1588-1603. CrossRef Medline
29. 2+ entry through non-α7 nicotinic acetylcholine receptors. Eur J Neurosci 31:463-476. CrossRef Medline
30. Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav 70:531-549. CrossRef Medline
31. Kim J (2008) Association of CHRNA2 polymorphisms with overweight/ obesity and clinical characteristics in a Korean population. Clin Chem Lab Med 46:1085-1089. CrossRef Medline
32. Kopchia KL, Altman HJ, Commissaris RL (1992) Effects of lesions of the central nucleus of the amygdala on anxiety-like behaviors in the rat. Pharmacol Biochem Behav 43:453-461. CrossRef Medline
33. Lamy JC, Iglesias C, Lackmy A, Nielsen JB, Katz R, Marchand-Pauvert V (2008) Modulation of recurrent inhibition from knee extensors to ankle motoneurones during human walking. J Physiol 586:5931-5946. CrossRef Medline
34. Léna C, Changeux JP, Mulle C (1993) Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J Neurosci 13:2680-2688. Medline
35. Lotfipour S, Arnold MM, Hogenkamp DJ, Gee KW, Belluzzi JD, Leslie FM (2011) The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition. Neuropharmacology 61:95-104. CrossRef Medline
36. Maciewicz R, Foote WE, Bry J (1981) Excitatory projection from the interpeduncular nucleus to central superior raphe neurons. Brain Res 225: 179-183. CrossRef Medline
37. McQuiston AR, Madison DV (1999) Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J Neurosci 19:2887-2896. Medline
38. Mészáros J, Gajewska S, Tarchalska-Kryñska B (1985) Habenulointerpeduncular lesions: the effects on pain sensitivity, morphine analgesia and open-field behavior in rats. Pol J Pharmacol Pharm 37:469-477. Medline
39. Morley BJ (1986) The interpeduncular nucleus. Int Rev Neurobiol 28:157-182. CrossRef Medline
40. Mulle C, Vidal C, Benoit P, Changeux JP (1991) Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulointerpeduncular system. J Neurosci 11:2588-2597. Medline
41. Nakauchi S, Brennan RJ, Boulter J, Sumikawa K (2007) Nicotine gates longterm potentiation in the hippocampal CA1 region via the activation of α2* nicotinic ACh receptors. Eur J Neurosci 25:2666-2681. CrossRef Medline
42. Nishikawa T, Fage D, Scatton B (1986) Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat. Brain Res 373:324-336. CrossRef Medline
43. Ophoff RA, Escamilla MA, Service SK, Spesny M, Meshi DB, Poon W, Molina J, Fournier E, Gallegos A, Mathews C, Neylan T, Batki SL, Roche E, Ramirez M, Silva S, De Mille MC, Dong P, Leon PE, Reus VI, Sandkuijl LA, et al. (2002) Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet 71:565-574. CrossRef Medline
44. Panchal V, Taraschenko OD, Maisonneuve IM, Glick SD (2005) Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine. Eur J Pharmacol 525:98-104. CrossRef Medline
45. Phillips RG, Le Doux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106:274-285. CrossRef Medline
46. Portugal GS, Wilkinson DS, Kenney JW, Sullivan C, Gould TJ (2012) Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Behav Genet 42:133-150. CrossRef Medline
47. Quinn JJ, Wied HM, Liu D, Fanselow MS (2009) Post-training excitotoxic lesions of the dorsal hippocampus attenuate generalization in auditory delay fear conditioning. Eur J Neurosci 29:1692-1700. CrossRef Medline
48. Raybuck JD, Gould TJ (2010) The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning. Neurobiol Learn Mem 94:353-363. CrossRef Medline
49. Raybuck JD, Lattal KM (2011) Double dissociation of amygdala and hippocampal contributions to trace and delay fear conditioning. PLo S One 6:e15982. CrossRef Medline
50. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8:711-713. CrossRef Medline
51. Salas R, Main A, Gangitano D, De Biasi M (2007) Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the α7 nicotinic acetylcholine receptor subunit. Neuropharmacology 53:863-869. CrossRef Medline
52. Salas R, Sturm R, Boulter J, De Biasi M (2009) Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J Neurosci 29:3014-3018. CrossRef Medline
53. Son JH, Winzer-Serhan UH (2006) Postnatal expression of α2 nicotinic acetylcholine receptor subunit m RNA in developing cortex and hippocampus. J Chem Neuroanat 32:179-190. CrossRef Medline
54. Sudweeks SN, Yakel JL (2000) Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol 527:515-528. CrossRef Medline
55. Sullivan PF, Neale BM, van den Oord E, Miles MF, Neale MC, Bulik CM, Joyce PR, Straub RE, Kendler KS (2004) Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics. Am J Med Genet B Neuropsychiatr Genet 126B:23-36. CrossRef Medline
56. Sutherland RJ, Nakajima S (1981) Self-stimulation of the habenular complex in the rat. J Comp Physiol Psychol 95:781-791. CrossRef Medline
57. Taraschenko OD, Shulan JM, Maisonneuve IM, Glick SD (2007) 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens. Synapse 61:547-560. CrossRef Medline
58. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson LW (1989) Distribution of α2, α3, α4, and β2 neuronal nicotinic receptor subunit m RNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284:314-335. CrossRef Medline
59. Wada K, Ballivet M, Boulter J, Connolly J, Wada E, Deneris ES, Swanson LW, Heinemann S, Patrick J (1988) Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptor. Science 240: 330-334. CrossRef Medline
60. Weinberger NM (2011) The medial geniculate, not the amygdala, as the root of auditory fear conditioning. Hear Res 274:61-74. CrossRef Medline
61. Whiteaker P, Wilking JA, Brown RW, Brennan RJ, Collins AC, Lindstrom JM, Boulter J (2009) Pharmacological and immunochemical characterization of α2* nicotinic acetylcholine receptors (n ACh Rs) in mouse brain. Acta Pharmacol Sin 30:795-804. CrossRef Medline